Suppr超能文献

双(硫代半卡巴腙)配体与细胞内铜结合蛋白之间的铜转移。对铜摄取机制和缺氧选择性的见解。

Transfer of copper between bis(thiosemicarbazone) ligands and intracellular copper-binding proteins. insights into mechanisms of copper uptake and hypoxia selectivity.

作者信息

Xiao Zhiguang, Donnelly Paul S, Zimmermann Matthias, Wedd Anthony G

机构信息

School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, 30 Flemington Road, University of Melbourne, Parkville, Victoria 3010, Australia.

出版信息

Inorg Chem. 2008 May 19;47(10):4338-47. doi: 10.1021/ic702440e. Epub 2008 Apr 16.

Abstract

Bis(thiosemicarbazonato) complexes Cu(II)(Btsc) have attracted interest as promising metallodrugs and, in particular, as copper radiopharmaceuticals. Prototypes Cu(Atsm) and Cu(Gtsm) are membrane-permeable, but their metabolisms in cells are distinctly different: copper that is delivered by Cu(Gtsm) is trapped nonselectively in all cells, whereas copper that is delivered by Cu(Atsm) is retained selectively in hypoxic cells but is "washed out" readily in normal cells. We have studied copper-transfer reactions of these two complexes under various conditions, aiming to model their cellular chemistry. In Me2SO, both complexes exhibited reversible one-electron-reduction processes with Cu(Atsm) being more difficult to reduce than Cu(Gtsm) (E(1/2)'=-0.60 and -0.44 V, respectively, vs AgCl/Ag). Upon introduction of an aqueous buffer into Me2SO, the electrochemical reduction remained chemically reversible for Cu(Atsm) but became irreversible for Cu(Gtsm). However, the estimated difference in their reduction potentials did not change. Chromophoric ligand anions bicinchonate (Bca) and bathocuproine disulfonate (Bcs) were used as Cu(I) indicators to trace the destinations of copper in the reactions and to mimic cellular Cu(I)-binding components ("sinks"). While both BtscH2 ligands have high affinities for Cu(I) (KD in the picomolar range), they cannot compete with Cu(I) sinks such as the copper-binding proteins Atx1 and Ctr1c (or a mimic such as Bcs). In the presence of these proteins, reduction of Cu(II)(Btsc) leads to irreversible transfer of copper to the protein ligands. Endogenous reductants ascorbate and glutathione can reduce Cu(II)(Gtsm) in the presence of such protein ligands but cannot reduce Cu(II)(Atsm). These properties establish a strong correlation between the contrasting cellular retention properties of these complexes and their different reduction potentials. The endogenous reductants in normal cells appear to be able to reduce Cu(II)(Gtsm) but not Cu(II)(Atsm), allowing the latter to be washed out. The more reducing environment of hypoxic cells leads to reduction of Cu(II)(Atsm) and retention of its copper.

摘要

双(硫代氨基脲)配合物Cu(II)(Btsc)作为有前景的金属药物,尤其是作为铜放射性药物,已引起人们的关注。原型Cu(Atsm)和Cu(Gtsm)具有膜通透性,但它们在细胞内的代谢明显不同:由Cu(Gtsm)递送的铜在所有细胞中被非选择性捕获,而由Cu(Atsm)递送的铜选择性地保留在缺氧细胞中,但在正常细胞中很容易“被清除”。我们研究了这两种配合物在各种条件下的铜转移反应,旨在模拟它们的细胞化学过程。在二甲基亚砜(Me2SO)中,两种配合物都表现出可逆的单电子还原过程,Cu(Atsm)比Cu(Gtsm)更难还原(相对于AgCl/Ag,E(1/2)'分别为-0.60和-0.44 V)。将水性缓冲液引入Me2SO后,Cu(Atsm)的电化学还原在化学上仍然可逆,但Cu(Gtsm)的则变为不可逆。然而,它们还原电位的估计差异没有变化。发色配体阴离子双喹啉甲酸(Bca)和 bathocuproine 二磺酸盐(Bcs)用作Cu(I)指示剂,以追踪反应中铜的去向,并模拟细胞内Cu(I)结合成分(“汇”)。虽然两种BtscH2配体对Cu(I)都有高亲和力(KD在皮摩尔范围内),但它们不能与Cu(I)汇竞争,如铜结合蛋白Atx1和Ctr1c(或类似物如Bcs)。在这些蛋白质存在的情况下,Cu(II)(Btsc)的还原导致铜不可逆地转移到蛋白质配体上。内源性还原剂抗坏血酸和谷胱甘肽在这种蛋白质配体存在时可以还原Cu(II)(Gtsm),但不能还原Cu(II)(Atsm)。这些性质在这些配合物截然不同的细胞保留特性与其不同的还原电位之间建立了很强的相关性。正常细胞中的内源性还原剂似乎能够还原Cu(II)(Gtsm),但不能还原Cu(II)(Atsm),从而使后者被清除。缺氧细胞中更强的还原环境导致Cu(II)(Atsm)的还原及其铜的保留。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验